Late-Breaking Studies Affecting Patient Outcomes I (SCCM 2026) - Mar 17, 2026 - Pres time: Mar 22, 2026; 03:15 PM - 04:15 PM; Location: Skyline Ballroom, W375D; "Learning Objectives: • Evaluate evidence from a multinational phase II trial, which found that early endotracheal poractant alfa did not reduce duration of invasive mechanical ventilation or improve clinical outcomes in critically ill infants with bronchiolitis • Describe the key components of the OCEAN‑ICU tool • Examine the association between polyunsaturated fatty acid levels and organ injury in pediatric sepsis • Review current recommendations on procalcitonin use in the emergency department for suspected sepsis and describe the methods and primary findings of the UK PRONTO Trial • Analyze the relationship between age and life-sustaining therapy (LST) limitation by describing the Ethicus-2 age substudy and summarizing the adjusted odds of any LST limitation in patients aged 80 and older versus younger than 65 Learning Objectives: • Evaluate evidence from a multinational phase II trial, which found that early endotracheal poractant alfa did not reduce duration..."
Clinical • Late-breaking abstract • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Septic Shock
|